Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 316,122 | 184,332 | 305,545 | 357,966 | 242,585 |
| Marketable Securities | 294,324 | 403,375 | 293,073 | 237,033 | 54,571 |
| Receivables | 72,327 | 144,330 | 210,445 | 218,312 | 374,951 |
| Inventories | 193,432 | 213,305 | 211,810 | 229,116 | 242,723 |
| Other current assets | 84,114 | 97,260 | 54,758 | 60,440 | 62,749 |
| TOTAL | $960,319 | $1,042,602 | $1,075,631 | $1,102,867 | $977,579 |
| Non-Current Assets | |||||
| PPE Net | 852,688 | 858,726 | 0 | 0 | 0 |
| Investments And Advances | 88,580 | 91,870 | 100,460 | 110,060 | 117,630 |
| Other Non-Current Assets | 214,710 | 231,180 | 357,430 | 369,710 | 541,010 |
| TOTAL | $1,155,978 | $1,181,776 | $457,890 | $479,770 | $658,640 |
| Total Assets | $1,524,842 | $1,637,527 | $1,821,244 | $1,880,938 | $1,946,925 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 152,560 | 0 |
| Accounts payable and accrued liabilities | 39,210 | 50,830 | 73,270 | 59,440 | 72,440 |
| Accrued Expenses | 78,490 | 109,170 | 121,080 | 130,430 | 153,100 |
| Other current liabilities | 8,080 | 14,780 | 24,070 | 41,480 | 53,140 |
| TOTAL | $253,563 | $305,222 | $347,925 | $383,927 | $294,180 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 1,325 | 1,447 | 154,227 |
| Other Non-Current Liabilities | 79,360 | 85,520 | 75,100 | 73,520 | 75,550 |
| TOTAL | $79,360 | $85,520 | $76,425 | $74,967 | $229,777 |
| Total Liabilities | $332,930 | $390,745 | $424,355 | $458,896 | $523,964 |
| Shareholders' Equity | |||||
| Common Shares | 1,169,110 | 1,158,630 | 1,165,480 | 1,173,190 | 1,165,070 |
| Retained earnings | 33,589 | 99,981 | 233,767 | 245,100 | 252,149 |
| Other shareholders' equity | -10,787 | -11,829 | -2,358 | 3,752 | 5,742 |
| TOTAL | $1,191,912 | $1,246,782 | $1,396,889 | $1,422,042 | $1,422,961 |
| Total Liabilities And Equity | $1,524,842 | $1,637,527 | $1,821,244 | $1,880,938 | $1,946,925 |